These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10331115)

  • 21. High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.
    Nordström AL; Farde L; Halldin C
    Psychopharmacology (Berl); 1993; 110(3):365-7. PubMed ID: 7831432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder.
    Potkin SG; Keator DB; Kesler-West ML; Nguyen DD; van Erp TG; Mukherjee J; Shah N; Preda A
    CNS Spectr; 2014 Apr; 19(2):176-81. PubMed ID: 24073841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study.
    Gefvert O; Lundberg T; Wieselgren IM; Bergström M; Långström B; Wiesel F; Lindström L
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):105-10. PubMed ID: 11313155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response.
    Nyberg S; Nakashima Y; Nordström AL; Halldin C; Farde L
    Br J Psychiatry Suppl; 1996 May; (29):40-4. PubMed ID: 8733822
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.
    Zipursky RB; Christensen BK; Daskalakis Z; Epstein I; Roy P; Furimsky I; Sanger T; Kapur S
    Can J Psychiatry; 2005 Jul; 50(8):462-9. PubMed ID: 16127964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy men.
    Andrée B; Halldin C; Vrijmoed-de Vries M; Farde L
    Psychopharmacology (Berl); 1997 Jun; 131(4):339-45. PubMed ID: 9226735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.
    Talbot PS; Laruelle M
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):503-11. PubMed ID: 12468013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study.
    Ito H; Arakawa R; Takahashi H; Takano H; Okumura M; Otsuka T; Ikoma Y; Shidahara M; Suhara T
    Int J Neuropsychopharmacol; 2009 Jun; 12(5):667-75. PubMed ID: 18937879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The D2 receptor occupancy profile of loxapine determined using PET.
    Kapur S; Zipursky RB; Jones C; Remington GJ; Wilson AA; DaSilva J; Houle S
    Neuropsychopharmacology; 1996 Dec; 15(6):562-6. PubMed ID: 8946430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V; Mulligan RS; Acton PD; Ohlsen RI; Pike VW; Ell PJ; Gacinovic S; Kerwin RW; Pilowsky LS
    Psychopharmacology (Berl); 2000 Jun; 150(2):132-40. PubMed ID: 10907666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian).
    Hodé Y; Reimold M; Demazières A; Reischl G; Bayle F; Nuss P; Hameg A; Dib M; Macher JP
    Psychopharmacology (Berl); 2005 Jul; 180(2):377-84. PubMed ID: 15948013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
    Kapur S; Zipursky R; Jones C; Remington G; Houle S
    Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amoxapine as an atypical antipsychotic: a comparative study vs risperidone.
    Apiquian R; Fresan A; Ulloa RE; de la Fuente-Sandoval C; Herrera-Estrella M; Vazquez A; Nicolini H; Kapur S
    Neuropsychopharmacology; 2005 Dec; 30(12):2236-44. PubMed ID: 15956984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
    Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y
    J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Receptor occupancy and antipsychotic drug action measured by PET and SPECT].
    Okubo Y; Suhara T
    Seishin Shinkeigaku Zasshi; 2001; 103(4):329-40. PubMed ID: 11392846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.
    Remington G; Kapur S
    J Clin Psychiatry; 1999; 60 Suppl 10():15-9. PubMed ID: 10340683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.